Pharmaceuticals

Sun Pharmaceutical Industries announced the appointment of Ms. Satyavati Berera as an Independent Director for a five-year term, subject to shareholder approval. The appointment was approved by the co

Senores Pharmaceuticals announces a joint venture, Amerisyn LLC, to target U.S. federal, veteran, and military supply contracts. The JV leverages Senores' manufacturing and R&D to supply pharmaceutica

Senores Pharmaceuticals' US subsidiary formed a joint venture, Amerisyn LLC, in North Carolina, USA. The wholly-owned US subsidiary, Senores Pharmaceuticals Inc., subscribed to a 70% membership intere

Bliss GVS Pharma's board approved the appointment of two new independent directors, Vijayanarayanan Mahadevan and Deepak Rameshchandra Shah, for a five-year term. The appointments, effective from Apri

Beta Drugs Limited issued a clarification to the National Stock Exchange regarding observations on a corrigendum to the Extraordinary General Meeting notice. The disclosure includes a detailed shareho

Sanofi India's board recommended a final dividend of ₹48 per share for FY25, subject to approval at the AGM. The company communicated TDS details to shareholders, with a record date of April 22, 2026,

Sanofi India Limited has scheduled its 70th Annual General Meeting (AGM) for April 29, 2026, to be held virtually. The company has proposed a final dividend of ₹48 per share, with a record date of Apr

Three acquirers are making an open offer for 26% of Rekvina Laboratories at ₹10 per share, totaling ₹2.89 crore. The offer is triggered by a share swap for Radiant Parenterals and is made under SEBI's

NCLT approves convening shareholder and creditor meetings for the amalgamation of J.B. Chemicals & Pharmaceuticals with Torrent Pharmaceuticals. The appointed date for the scheme is 21st January 2026,

The Union Budget 2026-27 increases the Ministry of Health and Family Welfare allocation by 10% to ₹1,06,530.42 crore, focusing on universal healthcare and infrastructure. Key initiatives include a 100

The Department of Pharmaceuticals organized a webinar on AI and emerging technologies in pharmaceuticals and regulations on 04 April 2026. The webinar highlighted AI's role in drug discovery, developm

Union Minister Dr. Jitendra Singh and IDF President-elect Dr. Niti Pall discussed scaling up indigenous production of biosimilar insulin and diabetes care devices. The meeting highlighted global insul

The Department of Pharmaceuticals, with FICCI and IPA, will host the 9th India Pharma 2026 conference in New Delhi on April 13-14, 2026. The conference aims to position India as a global hub for life

Venus Remedies files SEBI SAST Regulation 31(4) compliance for FY26, confirming no new share pledges by promoters. Promoters and promoter group declare no encumbrance or pledging of equity shares as o

Aarti Pharmalabs Limited has launched the IEPFA's 'Saksham Niveshak' campaign to facilitate the settlement of unpaid and unclaimed dividends for its shareholders. The 100-day campaign, from April 1 to

Granules India's US subsidiary, Granules Pharmaceuticals, Inc., has completed a routine cGMP audit by the US FDA at its Chantilly facility. The audit, conducted from March 30 to April 3, 2026, resulte

Colinz Laboratories declared Regulation 32 of SEBI LODR Regulations, 2015 as non-applicable for the quarter ended 31.03.2026. The company stated it made no public issue, rights issue, preferential iss

The Supreme Court listed the special leave petition filed by Mridang Pharma for hearing on 10.04.2026. The case involves Mridang Pharma and the Station House Officer & others. The case was heard on 01

The Supreme Court of India adjourned the transfer petition filed by Macleods Pharmaceuticals against Boehringer Ingelheim to 13 April 2026. The adjournment was granted following a request by the petit

SEBI confirms interim order halting Par Drugs' slump sale to a promoter entity, citing undervaluation and disclosure lapses. Independent valuation ordered after SEBI found the proposed sale undervalue